Success Story: Pediatric Cancer Research Earns NIW Approval in Just 2 Months and 10 Days

Client’s Testimonial:

 

"It has been a great experience working with your team and everything was so nicely outlined and handled. I appreciate all the answers to my questions in a prompt manner and thank you for keeping me always informed about everything regarding my application."

 


 

On July 17th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Scientist in the Field of Cancer Biology (Approval Notice).

 


 

General Field: Cancer Biology

 

Position at the Time of Case Filing: Postdoctoral Scientist

 

Country of Origin: India

 

State of Residence at the Time of Filing: Ohio

 

Approval Notice Date: July 17th, 2026

 

Processing Time: 2 months, 10 days (Premium Processing Requested)

 


 

Case Summary:

 

The client's proposed endeavor focuses on investigating how complex genetic mutations drive aggressive early-childhood cancers by integrating advanced molecular biology, high-throughput genomic sequencing, and functional in vivo and in vitro modeling. The goal is to identify precise molecular targets capable of suppressing tumor progression while advancing the scientific understanding of genetically driven pediatric malignancies. The petition further demonstrated that this work supports national priorities in specialized oncology by laying the groundwork for more precise therapeutic strategies and improved clinical outcomes.

 

To establish that the client was well positioned to continue advancing this endeavor, North America Immigration Law Group (Chen Immigration Law Associates) presented evidence of sustained scholarly productivity and research impact. At the time of filing, the client's credentials included:

 

  • 7 peer-reviewed journal articles
  • 7 conference abstracts
  • 1 first-authored book chapter
  • 51 citations from the scientific literature
  • 1 publication ranked among the top 10% most cited Molecular Biology & Genetics papers for its publication year.

 

These accomplishments demonstrated both technical expertise and growing recognition within the cancer biology community.

 

The petition also highlighted that the client's research had been independently relied upon by other investigators studying tumor biology, epithelial-mesenchymal transition, extracellular matrix mechanics, and pediatric cancer mechanisms. These examples showed that the client's findings had become valuable references for researchers seeking to better understand cancer progression and identify new therapeutic targets for rare pediatric malignancies, reinforcing the broader scientific influence of the client's work.

 

We are honored that our firm could assist in securing this NIW approval. By demonstrating how the client's research advances the understanding of pediatric cancer biology and supports the development of more precise therapeutic strategies, we helped establish that the client's continued work serves the national interest of the United States.